Guanzhong Wu

913 total citations
24 papers, 745 citations indexed

About

Guanzhong Wu is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guanzhong Wu has authored 24 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guanzhong Wu's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Enzyme Catalysis and Immobilization (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Guanzhong Wu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Enzyme Catalysis and Immobilization (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Guanzhong Wu collaborates with scholars based in China. Guanzhong Wu's co-authors include Nouredine Behloul, Qidi Ying, Hongbin Sun, Luyong Zhang, Jun Liu, Xiaoming Wu, Lifen Qian, Qian Yu, Xiaoan Wen and Hongxia Yang and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Information Sciences.

In The Last Decade

Guanzhong Wu

22 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanzhong Wu China 10 368 153 104 88 85 24 745
George S.G. Shehatou Egypt 15 248 0.7× 101 0.7× 46 0.4× 81 0.9× 59 0.7× 31 638
Xiaqing Wu China 17 413 1.1× 248 1.6× 98 0.9× 43 0.5× 81 1.0× 22 1.1k
Manisha J. Oza India 15 339 0.9× 120 0.8× 86 0.8× 36 0.4× 73 0.9× 21 832
Sana Irfan Khan India 15 321 0.9× 119 0.8× 133 1.3× 21 0.2× 107 1.3× 31 946
Guei‐Jane Wang Taiwan 23 509 1.4× 105 0.7× 58 0.6× 148 1.7× 173 2.0× 58 1.3k
Niloy Bhattacharjee India 11 347 0.9× 192 1.3× 48 0.5× 30 0.3× 89 1.0× 11 955
Mohamed A. El‐Moselhy Egypt 19 294 0.8× 149 1.0× 103 1.0× 33 0.4× 116 1.4× 39 975
Asjad Visnagri United Kingdom 11 285 0.8× 141 0.9× 58 0.6× 28 0.3× 142 1.7× 15 886
Nanjaian Mahadevan India 17 230 0.6× 105 0.7× 65 0.6× 30 0.3× 169 2.0× 37 814
Huiqin Xu China 17 391 1.1× 125 0.8× 33 0.3× 26 0.3× 91 1.1× 33 861

Countries citing papers authored by Guanzhong Wu

Since Specialization
Citations

This map shows the geographic impact of Guanzhong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanzhong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanzhong Wu more than expected).

Fields of papers citing papers by Guanzhong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanzhong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanzhong Wu. The network helps show where Guanzhong Wu may publish in the future.

Co-authorship network of co-authors of Guanzhong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guanzhong Wu. A scholar is included among the top collaborators of Guanzhong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanzhong Wu. Guanzhong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingkai, Guanzhong Wu, Yafang Zhang, Jiwei Wu, & Linsheng Wei. (2025). One-Step synthesis of mesoporous manganese silicate for efficient adsorption of methylene Blue, Rhodamine B, and Brilliant Green. Separation and Purification Technology. 379. 134953–134953. 2 indexed citations
2.
Li, Qing, et al.. (2024). Anomaly detection with dual-channel heterogeneous graph based on hypersphere learning. Information Sciences. 681. 121242–121242.
4.
Yu, Qian, et al.. (2019). Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway. Life Sciences. 225. 1–7. 71 indexed citations
5.
Qian, Lifen, Lingman Ma, Guanzhong Wu, et al.. (2017). G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice. Vascular Pharmacology. 89. 49–57. 13 indexed citations
6.
Ying, Qidi & Guanzhong Wu. (2017). Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update. Renal Failure. 39(1). 474–483. 98 indexed citations
7.
Zhang, Yan, et al.. (2016). Research progress in phytochemistry and biology ofAframomumspecies. Pharmaceutical Biology. 54(11). 2761–2770. 24 indexed citations
8.
Wang, Ying, et al.. (2016). Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice. European Journal of Pharmaceutical Sciences. 93. 123–131. 31 indexed citations
9.
Ma, Lingman, Lifen Qian, Qidi Ying, et al.. (2016). I 4 , a synthetic anti-diabetes agent, attenuates atherosclerosis through its lipid-lowering, anti-inflammatory and anti-apoptosis properties. Molecular and Cellular Endocrinology. 440. 80–92. 5 indexed citations
10.
Wu, Guanzhong, Zhen Zhang, Hong Chen, & Kejiang Lin. (2015). De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints. Bioorganic & Medicinal Chemistry Letters. 25(11). 2345–2352. 3 indexed citations
11.
Ma, Lingman, et al.. (2015). Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(8). 831–841. 8 indexed citations
13.
Behloul, Nouredine & Guanzhong Wu. (2012). Genistein: A promising therapeutic agent for obesity and diabetes treatment. European Journal of Pharmacology. 698(1-3). 31–38. 156 indexed citations
14.
15.
Wu, Guanzhong. (2011). Pull-out tests on anchoring force of prestressed anchor cables. 1 indexed citations
16.
Wu, Guanzhong & Xin Su. (2010). Antipruritic activity of extracts of Humulus scandens, the combinations of bioactive flavonoids. Fitoterapia. 81(8). 1073–1078. 3 indexed citations
17.
Wu, Guanzhong, et al.. (2009). Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutrition Research. 29(9). 656–663. 71 indexed citations
18.
Zhang, Huibin, et al.. (2009). Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents. Bioorganic & Medicinal Chemistry Letters. 19(6). 1740–1744. 38 indexed citations
19.
Chen, Jun, Jun Liu, Luyong Zhang, et al.. (2006). Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorganic & Medicinal Chemistry Letters. 16(11). 2915–2919. 87 indexed citations
20.
Wen, Xiaoan, Hongbin Sun, Jun Liu, et al.. (2005). Pentacyclic triterpenes. Part 1: The first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases. Bioorganic & Medicinal Chemistry Letters. 15(22). 4944–4948. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026